Non-small cell lung cancer (NSCLC), a leading cause of cancer-related deaths worldwide, remains a significant clinical challenge despite advances in immune checkpoint inhibitors therapy, with drug resistance persisting as a major obstacle. Palmitoylation, a critical post-translational modification (PTM) primarily catalyzed by palmitoyltransferases of the zinc finger DHHC-type (ZDHHC), has recently demonstrated important implications in NSCLC. This review aims to elucidate the mechanisms and clinical potential of ZDHHC-mediated protein palmitoylation in NSCLC progression and immune escape.
.
Humans ; Lipoylation ; Lung Neoplasms/pathology* ; Acyltransferases/genetics* ; Carcinoma, Non-Small-Cell Lung/pathology* ; Animals

Objective To explore the expression level of zinc finger CCCH-type containing 13 (ZC3H13)in gastric cancer based on bioinformatics techniques,along with clinicopathological stag-ing,prognostic survival,immune infiltration,correlation analysis,protein-protein interactions,and enrichment analysis.Methods Using the UALCAN database and the Gene Expression Profiling Inter-active Analysis(GEPIA)databases,the expression differences of ZC3H13 between normal gastric tis-sues and gastric cancer tissues,as well as the significance of clinical pathological data were compared.The correlation between ZC3H13 expression levels in gastric cancer tissues and patient survival progno-sis was assessed using univariate survival analysis through the Kaplan-Meier Plotter website and the GEPIA database.The relationship between ZC3H13 expression and immune infiltration levels in gastric cancer was explored using the Tumor Immune Estimation Resource(TIMER)database.Co-expression genes significantly correlated with ZC3H13 expression in gastric cancer were identified through the Linkedomics database.The protein-protein interaction network of ZC3H13 and its common target genes in gastric cancer was constructed using the STRING website,followed by Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses.Results Compared to normal gastric tissues,ZC3H13 was significantly upregulated in gastric cancer,and its high ex-pression was closely associated with patient age,ethnicity,tissue subtype,and other factors.Pa-tients with high ZC3H13 expression showed no statistically significant difference in overall survival(OS)or progression-free survival(PFS)time compared to patients with low expression(P＞0.05).Immune analysis revealed a significant negative correlation between ZC3H13 expression and the infiltration density of CD8+T cells,macrophages,neutrophils,and dendritic immune cells in gastric cancer(P＜0.05).Correlation analysis showed that ZC3H13 expression in gastric cancer was significantly positively correlated with the gene expression of DAK,DDK1,and BCL7C,and negatively correlated with the expression of FAM10A4,SLC6A7,and TAC1(P＜0.05).The pro-tein interaction network indicated that proteins interacting with ZC3H13 in gastric cancer included VIRMA,WTAP,METTL3,METTL14,RBM15,and others.Enrichment analysis revealed that dif-ferentially expressed genes in gastric cancer were mainly enriched in RNA polymerase,nucleotide excision repair,thyroid hormone signaling pathway,and other pathways.Conclusion ZC3H13 is overexpressed in gastric cancer,and its elevated expression is linked to the clinicopathological stage,patient survival time,and immune cell infiltration levels.Additionally,ZC3H13 may partici-pate in the initiation and progression of gastric cancer through interactions with key molecules such as VIRMA and METTL3.These findings suggest that ZC3H13 could serve as a potential biomarker and therapeutic target for gastric cancer prognosis.

Objective:To investigate the efficacy and safety of precise mechanical thrombectomy based on ABC 2D scale in acute intracranial large artery occlusion stroke (ALVOs). Methods:A prospective study was performed. Two hundred and two patients with ALVOs accepted early mechanical thrombectomy in Department of Neurology, Maoming Clinical School of Guangdong Medical University from January 2021 to February 2022 were enrolled. They were randomly divided into experimental group ( n=102) and control group ( n=100). Stent retriever partially retracted with intermediate catheter for mechanical thrombectomy (SWIM) was the first choice for patients in control group. ABC 2D scale was used to prejudge the pathogenesis of patients in experimental group: patients with scores of 0-3 were considered as having embolic occlusion and a direct aspiration first pass technique (ADAPT) was the first choice, and SWIM would be chosen if suction catheter could not be in place; patients with scores of 4-7 were considered as having intracranial atherosclerotic stenosis occlusion and SWIM was the first choice. The clinical data, surgical effectiveness, surgical safety, and good prognosis rate 90 d after mechanical thrombectomy (modified Rankin scale scores of 0-2 as good prognosis) of the 2 groups were compared. Results:Experimental group had significantly shorter time from puncture to recanalization (51.0[35.0, 78.5] min vs. 67.0[45.0, 100.0] min), and statistically lower NIHSS scores 24 h after mechanical thrombectomy (10.00[4.75, 16.25] vs. 13.00[8.00, 19.00]), significantly higher good prognosis rate 90 d after mechanical thrombectomy (69.6% vs. 46.0%), statistically lower mortality 90 d after mechanical thrombectomy (3.9% vs. 13.0%) compared with control group ( P<0.05). No significant differences were noted in first-pass effect rate, successful vascular revascularization rate, or incidences of symptomatic intracranial hemorrhage (sICH) and ectopic embolization between the control group and experimental group ( P>0.05). Conclusion:Patients with ALVOs accepted early mechanical thrombectomy can have shorter time from puncture to vascular recanalization and better prognosis after etiologically prejudging by ABC 2D scale for thrombectomy.